{"transactions":[{"id":674605,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-26T22:10:18.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":5800051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the total number of shares subject to the option will vest upon FDA approval of seralutinib, and 1/24th of the remaining 50% of the total number of shares subject to the option will vest on the last day of each one-month period after such FDA approval, in each case subject to the Reporting Person's continuous service to the Issuer on each such vesting date. To the extent FDA approval of seralutinib does not occur on or prior to the date that is two years following the grant date of the option, 1/24th of the total number of shares subject to the option will vest on the last day of each one-month period following the date that is two years following the grant date of the option, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":5800051,"derivative":{"exercise_price":0.175,"expiration_date":"2036-08-23","underlying":"Common Stock","underlying_shares":5800051},"source":{"system":"sec-edgar","filing":"0001740847-26-000006","document":"wk-form4_1787782215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000006/wk-form4_1787782215.xml","form_type":"4"}},{"id":674604,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2026-08-26T22:10:18.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":25,"price":999.999,"value":24999.975,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series A-1 non-voting convertible preferred stock is convertible automatically upon receipt of stockholder approval under applicable Nasdaq rules and regulations in connection with the\nIssuer's private placement pursuant to which the Pre-Funded Warrants were issued (\"Stockholder Approval\") into a number of shares of the Issuer's common stock equal to $1,000 divided by $0.14,\npursuant to the terms of the Series A-1 Certificate of Designation and subject to applicable beneficial ownership limitations."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrant has no expiration date and is exercisable immediately. Prior to the Issuer obtaining Stockholder Approval, the Pre-Funded Warrants are only exercisable for shares of Series\nA-1 non-voting convertible preferred stock. Following the Issuer's receipt of Stockholder Approval, the Pre-Funded Warrants are only exercisable for shares of the Issuer's common stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Series A-1 non-voting convertible preferred stock is convertible automatically upon receipt of stockholder approval under applicable Nasdaq rules and regulations in connection with the\nIssuer's private placement pursuant to which the Pre-Funded Warrants were issued (\"Stockholder Approval\") into a number of shares of the Issuer's common stock equal to $1,000 divided by $0.14,\npursuant to the terms of the Series A-1 Certificate of Designation and subject to applicable beneficial ownership limitations."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series A-1 non-voting convertible preferred stock is convertible automatically upon receipt of stockholder approval under applicable Nasdaq rules and regulations in connection with the\nIssuer's private placement pursuant to which the Pre-Funded Warrants were issued (\"Stockholder Approval\") into a number of shares of the Issuer's common stock equal to $1,000 divided by $0.14,\npursuant to the terms of the Series A-1 Certificate of Designation and subject to applicable beneficial ownership limitations."}],"balance_after":25,"derivative":{"exercise_price":0.0001,"exercise_date":"2026-08-24","underlying":"Series A-1 Preferred Stock","underlying_shares":25},"source":{"system":"sec-edgar","filing":"0001740847-26-000006","document":"wk-form4_1787782215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000006/wk-form4_1787782215.xml","form_type":"4"}},{"id":784586,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.98,"expiration_date":"2028-05-28","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784585,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.45,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784584,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-08","kind":"sale","planned":false,"acquired":false,"shares":5130,"price":100,"value":513000.0,"ownership":{"direct":true},"balance_after":12695,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784583,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-08","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":100,"value":600000.0,"ownership":{"direct":false,"nature":"By Bryan & Courtney Giraudo Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784582,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":100.07,"value":1200840.0,"ownership":{"direct":false,"nature":"By Bryan & Courtney Giraudo Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 10,000 shares of common stock that were previously held directly by the Reporting Person and which were transferred to the Bryan & Courtney Giraudo Trust."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784581,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":36000,"price":100.14,"value":3605040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $98.69 to $104.67. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":27825,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784580,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":6.98,"value":83760.0,"ownership":{"direct":true},"balance_after":43825,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":784579,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T00:25:57.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":6.45,"value":154800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 10,000 shares of common stock that were previously held directly by the Reporting Person and which were transferred to the Bryan & Courtney Giraudo Trust."}],"balance_after":31825,"source":{"system":"sec-edgar","filing":"0001104659-26-058860","document":"tm2614277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/tm2614277-1_4seq1.xml","form_type":"4"}},{"id":831885,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":96667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":96667,"derivative":{"exercise_price":0.45,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":96667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831884,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":47667,"derivative":{"exercise_price":0.45,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831883,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831882,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-09-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831881,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":176667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":176667,"derivative":{"exercise_price":0.45,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":176667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831880,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":211500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":211500,"derivative":{"exercise_price":0.45,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831879,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":211500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":211500,"derivative":{"exercise_price":0.45,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831878,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":181250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":181250,"derivative":{"exercise_price":0.45,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":181250},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831877,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":543750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":543750,"derivative":{"exercise_price":0.45,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":543750},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831876,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":638000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":638000,"derivative":{"exercise_price":0.45,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":638000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831875,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":693750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":693750,"derivative":{"exercise_price":0.45,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":693750},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831874,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":96667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":96667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831873,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831872,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831871,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831870,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":176667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":176667},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831869,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":211500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831868,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":211500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831867,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":181250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":181250},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831866,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":543750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":543750},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831865,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":638000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":638000},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":831864,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:16:53.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":693750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":693750},"source":{"system":"sec-edgar","filing":"0001740847-26-000004","document":"wk-form4_1774037809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000004/wk-form4_1774037809.xml","form_type":"4"}},{"id":946155,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:41:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":3762,"derivative":{"exercise_price":87.18,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":3762},"source":{"system":"sec-edgar","filing":"0001104659-26-001477","document":"tm262304-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926001477/tm262304-6_4seq1.xml","form_type":"4"}},{"id":946154,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:41:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":17825,"source":{"system":"sec-edgar","filing":"0001104659-26-001477","document":"tm262304-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926001477/tm262304-6_4seq1.xml","form_type":"4"}},{"id":949844,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:39:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":693750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option will vest on January 2, 2027 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":693750,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":693750},"source":{"system":"sec-edgar","filing":"0001740847-26-000002","document":"wk-form4_1767649172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000002/wk-form4_1767649172.xml","form_type":"4"}},{"id":949843,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2026-01-05T21:39:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":115750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in four equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":389737,"source":{"system":"sec-edgar","filing":"0001740847-26-000002","document":"wk-form4_1767649172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084726000002/wk-form4_1767649172.xml","form_type":"4"}},{"id":1026438,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2025-10-02T20:13:32.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":181250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":273987,"source":{"system":"sec-edgar","filing":"0001740847-25-000003","document":"wk-form4_1759436009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000174084725000003/wk-form4_1759436009.xml","form_type":"4"}},{"id":1218930,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-06T21:04:10.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":638000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":638000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":638000},"source":{"system":"sec-edgar","filing":"0001728117-25-000010","document":"wk-form4_1741295043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811725000010/wk-form4_1741295043.xml","form_type":"4"}},{"id":1310228,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T23:07:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 12 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":6584,"derivative":{"exercise_price":38.98,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6584},"source":{"system":"sec-edgar","filing":"0001104659-25-001428","document":"tm252003-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001428/tm252003-3_4seq1.xml","form_type":"4"}},{"id":1310227,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T23:07:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":15130,"source":{"system":"sec-edgar","filing":"0001104659-25-001428","document":"tm252003-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001428/tm252003-3_4seq1.xml","form_type":"4"}},{"id":1472724,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2024-06-21T00:21:38.000Z","date":"2024-06-18","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.5911,"value":59110.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,430 shares, with the Reporting Person's sale of 6,430 shares of common stock at a price of $1.1556 per share on March 27, 2024. The reporting person has agreed to pay to the Issuer $3,653.10, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs."}],"balance_after":480010,"source":{"system":"sec-edgar","filing":"0001728117-24-000073","document":"wk-form4_1718929291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000073/wk-form4_1718929291.xml","form_type":"4"}},{"id":1558182,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2024-03-28T22:05:34.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":6430,"price":1.1556,"value":7430.508,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.1551 to $1.165 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":92737,"source":{"system":"sec-edgar","filing":"0001728117-24-000039","document":"wk-form4_1711663523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000039/wk-form4_1711663523.xml","form_type":"4"}},{"id":1687504,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T01:10:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":25700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":25700,"derivative":{"exercise_price":23.42,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001104659-24-001491","document":"tm241954-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465924001491/tm241954-3_4seq1.xml","form_type":"4"}},{"id":1686852,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:02:36.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":543750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":543750,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":543750},"source":{"system":"sec-edgar","filing":"0001728117-24-000004","document":"wk-form4_1704405725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000004/wk-form4_1704405725.xml","form_type":"4"}},{"id":1730718,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-23T00:07:42.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":181250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":181250,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":181250},"source":{"system":"sec-edgar","filing":"0001728117-23-000147","document":"wk-form4_1700698050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000147/wk-form4_1700698050.xml","form_type":"4"}},{"id":1741864,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2023-11-14T23:24:19.000Z","date":"2023-11-13","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":0.5644,"value":112880.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.5557 to $0.5723 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":380010,"source":{"system":"sec-edgar","filing":"0001728117-23-000136","document":"wk-form4_1700004245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000136/wk-form4_1700004245.xml","form_type":"4"}},{"id":1822624,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2023-07-26T20:03:44.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":13505,"price":0.125,"value":1688.125,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":13505,"derivative":{"exercise_price":2.04,"exercise_date":"2023-07-24","expiration_date":"2028-07-24","underlying":"Common Stock Purchase Warrants","underlying_shares":13505},"source":{"system":"sec-edgar","filing":"0001728117-23-000100","document":"wf-form4_169040180880782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000100/wf-form4_169040180880782.xml","form_type":"4"}},{"id":1822623,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2023-07-26T20:03:44.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":54020,"price":1.82,"value":98316.4,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":180010,"source":{"system":"sec-edgar","filing":"0001728117-23-000100","document":"wf-form4_169040180880782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000100/wf-form4_169040180880782.xml","form_type":"4"}},{"id":1899121,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":176667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 176,677 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":176667,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":176667},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899120,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on September 16, 2021. In exchange for the canceled option, the reporting person received 100,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the total number of shares subject to the option vested on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.36,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899119,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899118,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":47667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":47667,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":47667},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899117,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":96667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 96,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":96667,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":96667},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899116,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":265000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 176,677 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899115,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on September 16, 2021. In exchange for the canceled option, the reporting person received 100,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the total number of shares subject to the option vested on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.54,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899114,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 60,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.79,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899113,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":71500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 47,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1899112,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:15:00.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":145000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 96,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.1,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001728117-23-000053","document":"wf-form4_168366328309495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000053/wf-form4_168366328309495.xml","form_type":"4"}},{"id":1924507,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2023-04-05T20:26:03.000Z","date":"2023-04-04","kind":"purchase","planned":false,"acquired":true,"shares":55000,"price":1.0199,"value":56094.5,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.0198 to $1.02 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":125990,"source":{"system":"sec-edgar","filing":"0001728117-23-000032","document":"wf-form4_168072635273012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000032/wf-form4_168072635273012.xml","form_type":"4"}},{"id":1941131,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T21:17:06.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":211500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":211500,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001728117-23-000020","document":"wf-form4_167951981146427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000020/wf-form4_167951981146427.xml","form_type":"4"}},{"id":1941130,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2023-03-22T21:17:06.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.9687,"value":48435.0,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":70990,"source":{"system":"sec-edgar","filing":"0001728117-23-000020","document":"wf-form4_167951981146427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000020/wf-form4_167951981146427.xml","form_type":"4"}},{"id":2052252,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T01:13:05.000Z","date":"2023-01-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 equal monthly installments following the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":12.17,"expiration_date":"2033-01-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-23-004739","document":"tm233829-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465923004739/tm233829-6_4seq1.xml","form_type":"4"}},{"id":2090750,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T22:15:26.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":211500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on December 7, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":211500,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":211500},"source":{"system":"sec-edgar","filing":"0001728117-22-000106","document":"wf-form4_167062410024328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000106/wf-form4_167062410024328.xml","form_type":"4"}},{"id":2206766,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2022-07-15T20:23:00.000Z","date":"2022-07-15","kind":"purchase","acquired":true,"shares":13869,"price":7.21,"value":99995.49,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,722 shares, with the Reporting Person's sale of 10,722 shares of common stock at a price of $8.915 per share on March 23, 2022. The Reporting Person paid to the Issuer $18,281.01, representing the full amount of the profit realized in connection with the short-swing transaction."}],"balance_after":20990,"source":{"system":"sec-edgar","filing":"0001728117-22-000061","document":"wf-form4_165791656527611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000061/wf-form4_165791656527611.xml","form_type":"4"}},{"id":2253127,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T20:00:29.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of (i) May 26, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":20000,"derivative":{"exercise_price":8.31,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-065859","document":"tm2214526-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922065859/tm2214526-3_4seq1.xml","form_type":"4"}},{"id":2318553,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2022-03-24T20:53:28.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":10722,"price":8.915,"value":95586.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":99167,"source":{"system":"sec-edgar","filing":"0001728117-22-000029","document":"wf-form4_164815518548512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000029/wf-form4_164815518548512.xml","form_type":"4"}},{"id":2438628,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T21:05:48.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":265000,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001728117-22-000004","document":"wf-form4_164184871170973.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000004/wf-form4_164184871170973.xml","form_type":"4"}},{"id":2563667,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-20T20:25:02.000Z","date":"2021-09-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on September 16, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date"}],"balance_after":150000,"derivative":{"exercise_price":10.54,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001728117-21-000091","document":"wf-form4_163216948450731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000091/wf-form4_163216948450731.xml","form_type":"4"}},{"id":2691047,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T22:39:24.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":18000,"derivative":{"exercise_price":35.23,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-21-036662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919121036662/doc4.xml","form_type":"4"}},{"id":2771611,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-25T20:11:38.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":5490,"price":9.4801,"value":52045.749,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":109889,"source":{"system":"sec-edgar","filing":"0001728117-21-000031","document":"wf-form4_161670308383086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000031/wf-form4_161670308383086.xml","form_type":"4"}},{"id":2825124,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T21:50:20.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option will vest on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":90000,"derivative":{"exercise_price":9.79,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001728117-21-000023","document":"wf-form4_161463539991270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000023/wf-form4_161463539991270.xml","form_type":"4"}},{"id":2825123,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-01T21:50:20.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":115379,"source":{"system":"sec-edgar","filing":"0001728117-21-000023","document":"wf-form4_161463539991270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000023/wf-form4_161463539991270.xml","form_type":"4"}},{"id":3006740,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-14T23:27:04.000Z","date":"2020-10-14","kind":"purchase","acquired":true,"shares":3000,"price":10.012,"value":30036.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $9.41 to $10.31 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request."}],"balance_after":7121,"source":{"system":"sec-edgar","filing":"0001209191-20-054839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919120054839/doc4.xml","form_type":"4"}},{"id":3101459,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-23T21:01:41.000Z","date":"2020-06-23","kind":"purchase","acquired":true,"shares":2000,"price":12.9612,"value":25922.4,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $12.9606 to $12.962 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request."}],"balance_after":4121,"source":{"system":"sec-edgar","filing":"0001209191-20-038515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919120038515/doc4.xml","form_type":"4"}},{"id":3130437,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T22:12:01.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) May 28, 2021, or (ii) the date of the 2021 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":15000,"derivative":{"exercise_price":16.54,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-033016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919120033016/doc4.xml","form_type":"4"}},{"id":3261807,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:20:06.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":71500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option will vest on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":71500,"derivative":{"exercise_price":14.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001209191-20-010515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919120010515/doc4.xml","form_type":"4"}},{"id":3261806,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-19T21:20:06.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":70379,"source":{"system":"sec-edgar","filing":"0001209191-20-010515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919120010515/doc4.xml","form_type":"4"}},{"id":3353949,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-03T23:46:06.000Z","date":"2019-12-03","kind":"purchase","acquired":true,"shares":8000,"price":5.7025,"value":45620.0,"ownership":{"direct":false,"nature":"By Bryan & Courtney Giraudo Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $5.565 to $5.81, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-058853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119058853/doc4.xml","form_type":"4"}},{"id":3405660,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-26T20:08:50.000Z","date":"2019-09-26","kind":"purchase","acquired":true,"shares":1121,"price":16.7798,"value":18810.1558,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":2121,"source":{"system":"sec-edgar","filing":"0001209191-19-050863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119050863/doc4.xml","form_type":"4"}},{"id":3493946,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T22:20:33.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":12000,"derivative":{"exercise_price":11.8,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-036195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119036195/doc4.xml","form_type":"4"}},{"id":3504224,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-03T20:03:21.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":1000,"price":18.7,"value":18700.0,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-19-033844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119033844/doc4.xml","form_type":"4"}},{"id":3578032,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-26T22:45:58.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 25, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":145000,"derivative":{"exercise_price":22.1,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001209191-19-021363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119021363/doc4.xml","form_type":"4"}},{"id":3662329,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B Preferred Stock","published_at":"2019-02-12T22:33:11.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":23316,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5181},"source":{"system":"sec-edgar","filing":"0001209191-19-009430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/doc4.xml","form_type":"4"}},{"id":3662328,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Preferred Stock","published_at":"2019-02-12T22:33:11.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":57142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12698},"source":{"system":"sec-edgar","filing":"0001209191-19-009430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/doc4.xml","form_type":"4"}},{"id":3662327,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-12T22:33:11.000Z","date":"2019-02-12","kind":"purchase","acquired":true,"shares":6000,"price":16,"value":96000.0,"ownership":{"direct":true},"balance_after":23879,"source":{"system":"sec-edgar","filing":"0001209191-19-009430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/doc4.xml","form_type":"4"}},{"id":3662326,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-12T22:33:11.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":17879,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date."}],"balance_after":17879,"source":{"system":"sec-edgar","filing":"0001209191-19-009430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/doc4.xml","form_type":"4"}},{"id":3896615,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-12T22:39:00.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":12000,"derivative":{"exercise_price":6.98,"expiration_date":"2028-05-28","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-037308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118037308/doc4.xml","form_type":"4"}},{"id":3927800,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T21:48:14.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of May 15, 2018."}],"balance_after":24000,"derivative":{"exercise_price":6.45,"expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-18-031121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118031121/doc4.xml","form_type":"4"}},{"id":3927799,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":19370,"kind":"person","name":"Giraudo Bryan","position":1,"cik":"0001740847","reported_name":"Giraudo Bryan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T21:48:14.000Z","date":"2017-05-16","kind":"purchase","acquired":true,"shares":10000,"price":6.4566,"value":64566.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $6.43 to $6.50, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-031121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118031121/doc4.xml","form_type":"4"}}]}